The Business Magazine - B2B Business News - Site Logo
The Business Magazine November 2023
Read now
PICK YOUR EDITION

Planning permission granted for the latest phase of development at Oxford Technology Park

24 January 2023
Share
The Business Magazine article image for: Planning permission granted for the latest phase of development at Oxford Technology Park
Oxford Technology Park

Planning permission has been secured for a new phase of development at Oxford Technology Park, providing the opportunity to build much needed lab-space.

Cherwell District Council has approved plans for three further hybrid buildings, to be located at the park.

Councillor Barry Wood, Leader of the council, said: "Innovation in science and technology and university spin-out investment frequently happens in clusters.

Angus Bates, Developer and  Director of Oxtec, said: “Despite the prevailing economic headwinds, we continue to see strong demand for space at Oxford Technology Park from a broad range of life science occupiers including gene therapy, quantum computing and AI businesses. Following on from our most recent letting to Oxford Ionics, we have interest in units ranging from 7500 sq ft at our Innovation Quarter to 40,000 sq ft in our larger, hybrid buildings. Having secured planning consent for the next phase of our development is crucial for us to continue to attract these high-value, fast-growing businesses to Oxford Technology Park with all the downstream benefits this brings to the local economy.”

https://www.businessinnovationmag.co.uk/oxford-ionics-raises-30-million-from-quantum-experts/

The new phase will be the fourth phase constructed so far on the 20-acre science and technology park, following the completion of the Innovation Quarter, a 49,000 sq ft HQ facility for The Native Antigen Company, the 34,125 sq.ft. landmark, lab-enabled office Building One and a 101-bedroom hotel and restaurant.

Aimed at accommodating the rapid growth of Oxford’s life science companies, the Hybrid Buildings provide office and advanced R&D laboratory space, from 17,000 sq.ft to 50,000 sq ft.

Angus added: “We don’t expect these buildings to be on the market for long. This particular style of state of the art office and advanced R&D laboratory commercial unit, which we first brought to the marketplace for The Native Antigen Company, has proven to be incredibly popular and generating a lot of interest among life science occupiers. We would encourage interested parties to get in touch and book a viewing.”

Completion of the Hybrid Buildings is expected at the end of 2023.


Nicky Godding is editor of The Business Magazine. Before her journalism career, she worked mainly in public relations moving into writing when she was invited to launch Retail Watch, a publication covering retail and real estate across Europe.

After some years of constant travelling, she tucked away her passport and concentrated on business writing, co-founding a successful regional business magazine. She has interviewed some of the UK’s most successful entrepreneurs who have built multi-million-pound businesses and reported on many science and technology firsts.

She reports on the region’s thriving business economy from start-ups, family businesses and multi-million-pound corporations, to the professionals that support their growth and the institutions that educate the next generation of business leaders.

Related topics

Related articles